IgG4-related dacryoadenitis  by Su, Pei-Yuan et al.
at SciVerse ScienceDirect
Taiwan Journal of Ophthalmology 3 (2013) 116e119Contents lists availableTaiwan Journal of Ophthalmology
journal homepage: www.e-t jo.comCase reportIgG4-related dacryoadenitis
Pei-Yuan Su a,*, Chien-Sheng Wub, Shu-Wen Chang a
aDepartment of Ophthalmology, Far-Eastern Memorial Hospital, New Taipei City, Taiwan
bDivision of Immunology and Rheumatology, Department of Internal Medicine, Far-Eastern Memorial Hospital, New Taipei City, Taiwana r t i c l e i n f o
Article history:
Received 19 February 2013
Received in revised form
24 April 2013
Accepted 6 May 2013
Available online 13 June 2013
Keywords:
dacryoadenitis
IgG4-related disease
lacrimal gland tumor
orbital inﬂammation* Corresponding author. Department of Ophthalm
Hospital, 21, Section 2, Nan-Ya South Road, Ban-Ch
Taiwan.
E-mail address: patsysu624@yahoo.com.tw (P.-Y. S
2211-5056/$ e see front matter Copyright  2013, Th
http://dx.doi.org/10.1016/j.tjo.2013.05.003a b s t r a c t
A 44-year-old female presented with bilateral eyelid swelling and painless, palpable mass over the
lacrimal gland area for more than 1 year. A bilateral enlarged lacrimal gland with mild contrast
enhancement was noted on computed tomography. Biopsy of the lacrimal gland showed lympho-
plasmacytic inﬁltrate with focal hyaline and sclerotic change, and immunohistochemical staining
revealed numerous IgG4-positive plasma cells, which was characteristic of IgG4 dacryoadentitis. Serum
IgG and IgG4 levels were within normal range. The patient was treated with surgical excision instead of
systemic steroid owing to poor tolerance. No tumor recurrence or systemic involvement was noted
during the follow-up period. Our case highlights the importance of IgG4 dacryoadenitis in differentiating
bilateral lacrimal gland inﬂammatory conditions. A normal serum IgG4 level does not rule out the
diagnosis and surgical excision may be an alternative for those who are considered ineligible for corti-
costeroid treatment.
Copyright  2013, The Ophthalmologic Society of Taiwan. Published by Elsevier Taiwan LLC. All rights
reserved.1. Introduction
IgG4-related diseases (IgG4 RDs) are recently described sys-
temic syndromes characterized by elevated serum IgG4 and IgG4-
positive lymphoplasmacytic inﬁltrative lesions in the body. The
ﬁrst reported casewas an autoimmune pancreatitis.1 Orbital tissues
can also be affected, and was ﬁrst reported by Yamamoto et al2 in a
case of Mikulicz’s disease, which is characterized by symmetrical
enlargement and hyposecretion of lacrimal and salivary glands.
Later on, IgG4 RDs involving different ocular adnexal tissues had
been reported.3e6 Orbital IgG4 RDs should be differentiated from
idiopathic orbital inﬂammation (IOI) and ocular adnexal lymphoma
to ensure appropriate treatment. We present a case of isolated
bilateral IgG4-related dacryoadenitis, which was conﬁrmed by
pathologic observation and treated with surgical excision. The
clinical presentation, pathologic ﬁndings of differential diagnosis,
and management of orbital IgG4 RDs are reviewed.ology, Far-Eastern Memorial
iao District, New Taipei City,
u).
e Ophthalmologic Society of Taiw2. Case report
A 44-year-old woman presented with progressive bilateral
eyelid swelling with mild erythematous change for 2 years.
Moreover, no pain or symptoms of dry eye was noted. Her medical
history was unremarkable except for a history of allergic rhinitis.
Clinical examination revealed a bilateral swollen eyelid with
palpable mass lesions in the lacrimal fossa, which were ﬁrm,
nontender, and not movable (Fig. 1). The visual acuity, intraocular
pressure, and eye movement were not affected. Hertel exophthal-
mometer measurements were 13 mm in both eyes. No ptosis or
abnormal eyelid shape was noted. Slit-lamp biomicroscopy and
fundoscopy examination were normal. Orbital computed tomog-
raphy showed circumscribed mass lesion within the bilateral
lacrimal fossa with mild contrast enhancement, and normal adja-
cent bony structure (Fig. 2). No adjacent sinus or deep orbital in-
vasion was noted. No systemic infection or inﬂammation signs
were noted according to the blood test. Thyroid function test result
was within normal limits. Serum IgG level was 1600mg/dL (normal
range: 700.0e1600.0 mg/dL) and IgG 4 level was 103 mg/dL
(normal range: 3.0e201.0 mg/dL). According to the clinical and
image studies, orbital pseudotumor or sclerosing dacryoadenitis
cannot be ruled out; therefore, oral prednisolone (30 mg/day) was
prescribed. However, lid swelling did not showmuch improvement
after 2 months. Excisional biopsy of the right lacrimal gland wasan. Published by Elsevier Taiwan LLC. All rights reserved.
Fig. 1. Clinical appearance showed bilateral upper eyelid swelling with mild skin
erythematous change. Physical examination revealed ﬁrm, nontender palpable mass
lesion over bilateral lacrimal gland fossa.
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with a relatively smooth surface (Fig. 3A). The pathology exami-
nation showed the following: ﬂorid mixed lymphoid, plasma cells
and scattered eosinophilic inﬁltrate, focal hyaline, and sclerotic
change (Fig. 3B and C); immunohistochemically, the number of
IgG4-positive plasma cells was >10 under high power ﬁeld (40),
and the ratio of the IgG4/IgG plasma cells was more than 50%
(Fig. 3D). The clinical and pathologic ﬁndings were consistent with
IgG4-related dacryoadenitis.
The postoperation course was smooth and showed substantial
improvement without any sign of dryness or ocular surface com-
plications (Fig. 4A). Excision of the left lacrimal gland was arranged
7 months after the ﬁrst surgery because of persistent swelling ofFig. 2. Computed tomography of orbitd(A) coronal view, (B) axial viewdrevealing
bilateral lacrimal gland enlargement (arrow) without adjacent bony destruction. The
tumors were mildly enhanced by contrast. No sinus or deep orbital invasion was noted.the left eyelid and poor tolerance of systemic steroids. The patho-
logic ﬁndings were still consistent with IgG4-related dacryoade-
nitis despite the normal serum IgG4 level. The patient had been
followed for more than 1 year and remained symptom-freewithout
other systemic involvement (Fig. 4B).
3. Discussion
IgG4 RDs are a relatively newly described disease entity used to
demonstrate ﬁbroinﬂammatory diseases occurring at various sites
of the body. It is characterized by elevated serum IgG4 (>135 mg/
dL) and histological observation of IgG4-positive plasma cell inﬁl-
tration (ratio of IgG4/IgG-positive cells>40% and>10 IgG4-positive
plasma cells/HPF) and ﬁbrosis of the affected organ.7 The ﬁrst re-
ported case of IgG4 RD is sclerosing pancreatitis.1 Other frequently
reported cases include retroperitoneal ﬁbrosis, Riedel thyroiditis,
panniculitis, sclerosing cholangitis, and sialadenitis.7
Orbital and ocular adnexal tissue can also be affected, and it was
ﬁrst reported by Yamamoto et al2 in 2005 for observation of
bilateral symmetric enlargement of lacrimal and salivary glands,
which was referred to as Mikulicz’s disease. The median age of
patients with orbital IgG4 RD is 59 years, and both sexes are equally
affected, except for bilateral lacrimal gland lesions, which is female-
predominant.2,4e6 The most reported common site of orbital IgG4
RDs is the lacrimal gland (69%), and it is usually bilaterally involved
(48%). Other sites reported include the extraocular muscle, the
infraorbital nerve, the optic nerve sheath, the lacrimal sac, the
cavernous sinus, or intracranial invasion.3e6,8
Orbital IgG4 RDs usually present as chronic lid swelling or
proptosis, with minimal inﬂammation or restriction of ocular
motility. Visual disturbance is rare, unless there is orbital apex
lesion. Most orbital IgG4 RDs present as the only site involved,
although some have other systemic lesions, such as those found in
submandibular glands, lymph nodes, pancreas, bile duct,4e6 or
thyroid and pituitary glands.9,10 Clinically, it should be differenti-
ated from IOI, which is characterized by acute onset of orbital
inﬂammation. Orbital IgG4 RDs have a more indolent course.
However, tissue biopsy is essential for making speciﬁc diagnosis. In
many cases with presumed IOI, like our case initially, patients do
not undergo biopsy, or IgG4 staining is not routinely performed
even if biopsy is done. As a result, an accurate diagnosis of orbital
IgG4 RD cannot be made.
Histopathologic ﬁndings of ocular IgG4 RD include marked
lymphoplasmacytic inﬁltration, lymphoid follicles, admixed with
dense ﬁbrosis, and abundant inﬁltration of IgG4-positive plasma
cells.6 IgG4-related dacryoadenitis has been considered a subtype
of Sjogren syndrome because of their pathological resemblance.
However, it differs from Sjogren syndrome in that patients with
IgG4-related dacryoadenitis lack anti-SS antibodies, and are char-
acterized with elevated serum IgG4 levels, numerous IgG4-positive
plasma cells, and maintained lacrimal gland function.11 Another
important disease that should be differentiated is ocular adnexal
marginal B-cell lymphoma, because some cases may show IgG4-
positive plasma cells and elevated serum IgG4 levels.12 Evidence
of light chain restriction by in situ hybridization and immuno-
globulin heavy chain gene rearrangement by Southern blotting
seen in lymphoma cases can differentiate between these diseases.
However, there are reports of ocular adnexal marginal B-cell lym-
phomas arising from IgG4-related dacryoadenitis.13 In our case,
Sjogren syndrome had been ruled out by blood test, and lymphoma
had not been noted by histopathologic examination. However,
long-term surveillance for malignant transformation may be
indicated.
The laboratory data of patients with orbital adnexal IgG4 RD
usually showed elevated serum IgG4. However, there are some
Fig. 3. (A) Lacrimal gland excised measured 2.5 cm  1.3 cm  0.5 cm in size with a relatively smooth surface. (B) Hematoxylineeosin stain of low power ﬁeld (40) showed
abundant inﬂammatory inﬁltrations in lacrimal ducts with focal hyaline and sclerosing changes (arrow). (C) Hematoxylineeosin stain of high power ﬁeld (100) showed that most
inﬁltrates comprise plasma cells. (D) Immunohistochemistry study (400) showed that a high proportion of plasma cells are positive for IgG4.
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For example, Cheuk et al14 reported six cases of IgG4-related
dacryoadenitis, and two out of four patients tested showed
normal serum IgG4 levels. Sato et al6 reported 21 cases of ocular
adnexal IgG4-RD, and three out of 13 patients tested had normal
serum IgG4 levels. Plaza et al5 reported 11 orbital IgG4-RD, and
three out of ﬁve patients tested had normal serum IgG4 levels.
Previous reports had suggested less possibility of systemic
involvement and better prognosis in these cases. Our case met only
the pathologic criteria of IgG4 RD, and we speculate that previous
systemic steroid treatment may confound the serum IgG4 level.
Treatment options for patients with IgG4 RD include systemic
steroids, radiotherapy, or immunosuppressants.4e6 CorticosteroidsFig. 4. (A) Seven months after excision of the right lacrimal gland, normal appearance of th
fossa (arrow) were observed. (B) Two months after excision of the left lacrimal gland, normare very effective, but recurrence had been observed after treat-
ment was discontinued.15 For those patients considered ineligible
for steroid or immunosuppressant therapy, surgical excision may
be an alternative.3 As for our patient, steroid therapy was tried
initially with minimal response and poor patient tolerance;
therefore, surgical excision of bilateral lacrimal glands was per-
formed with a satisfying outcome.
In conclusion, the case of IgG4-related dacryoadenitis presented
here falls under a new disease entity with unique laboratory and
pathologic ﬁndings. It should be considered as a differential diag-
nosis of bilateral lacrimal gland inﬂammatory conditions. A normal
serum IgG4 level does not rule out the diagnosis. Our case illus-
trates the importance of surgical biopsy and IgG4 staining ine right eye and persistent left upper eyelid swelling with palpable mass over lacrimal
al appearance of both eyes was noted.
P.-Y. Su et al. / Taiwan Journal of Ophthalmology 3 (2013) 116e119 119indeterminate cases. Accurate diagnosis is essential because of the
disease’s association with systemic involvement and lymphoma.
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